At a Glance
| Mexedrone | 2-Aminoindane | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 150–250 mg | 10–20 mg |
| Total Duration | — | 0.2–0.5 hrs |
| Routes | oral | oral |
| Effects | 21 documented | 27 documented |
Mexedrone, a Stimulants, and 2-Aminoindane, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 15 documented effects in common, with 6 effects unique to Mexedrone and 12 unique to 2-Aminoindane. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Mexedrone | 2-Aminoindane | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 150–250 mg | 10–20 mg |
| Total Duration | — | 0.2–0.5 hrs |
| Routes | oral | oral |
| Effects | 21 documented | 27 documented |
| Level | Mexedrone | 2-Aminoindane |
|---|---|---|
| Threshold | 50 mg | 3 mg |
| Light | 100–150 mg | 5–10 mg |
| Common | 150–250 mg | 10–20 mg |
| Strong | 250–350 mg | 20–40 mg |
| Heavy | — mg | 40 mg |
Mexedrone
2-Aminoindane
No direct interaction data available between these substances. This does not mean the combination is safe.